CRISPR Therapeutics AG Is This Gene Therapy Stock a Good Buy Right Now?
| UIAGX Fund | USD 72.57 0.36 0.50% |
Slightly above 53% of Aggressive Growth's investor base is interested to short. The analysis of overall sentiment of trading Aggressive Growth Fund mutual fund suggests that many investors are impartial at this time. Aggressive Growth's investing sentiment can be driven by a variety of factors including economic data, Aggressive Growth's earnings reports, geopolitical events, and overall market trends.
Aggressive |
We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where CRISPR Therapeutics AG stands against the other gene therapy stocks. Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or
Read at finance.yahoo.com
 |
Aggressive Growth Fundamental Analysis
We analyze Aggressive Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aggressive Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aggressive Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Aggressive Growth is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Aggressive Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aggressive Growth mutual fund to make a market-neutral strategy. Peer analysis of Aggressive Growth could also be used in its relative valuation, which is a method of valuing Aggressive Growth by comparing valuation metrics with similar companies.
Peers
Aggressive Growth Related Equities
| IPBAX | Inflation-protected | 0.19 | ||||
| LIFAX | Lord Abbett | 0.17 | ||||
| EVOIX | Altegris Futures | 0.15 | ||||
| APOIX | Short Duration | 0.1 | ||||
| TIIHX | Tiaa Cref | 0.1 |
Other Information on Investing in Aggressive Mutual Fund
Aggressive Growth financial ratios help investors to determine whether Aggressive Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aggressive with respect to the benefits of owning Aggressive Growth security.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |